STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug

How 1 sources are covering this

• STATCenter·3h ago

  STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug

  Patient advocates and some experts are expressing growing alarm over the perceived risks of a rare disease drug sold by Neurocrine Biosciences.

  Read at STAT →